EXPGF

EXPGF - Experian plc

BUYREDUCE ZONEIndustrials - Consulting ServicesAnalysis generated 2026-10-04Market data as of 2026-11-11Market data 4 days oldUSD 39.03

Conviction

out of 100

Executive Summary

Experian plc is a global data and analytics business that supplies credit reporting, decisioning software, fraud prevention and identity verification services to lenders, insurers, public-sector bodies and consumer customers across North America, Latin America, the UK and Ireland and Asia-Pacific. Its market position is that of one of the three principal credit reference agencies globally, with the listed US-market positioning falling within the Industrials sector and the Consulting Services industry classification used for reporting purposes. The franchise rests on regulated data assets, lender integrations and recurring contract structures, which together make it more than a passive credit-file repository.

The investment case hinges on continued organic revenue growth and benchmark earnings expansion at the rates demonstrated in recent reporting, supported by ongoing capital returns to shareholders via the share repurchase programme. The key near-term catalyst is the delivery of further half-year results due in November 2026, which we expect to confirm the organic growth and margin trajectory from the prior reporting period. The primary risk is heightened regulatory scrutiny around data use and consumer protection in Experian's principal markets, which could compress the rating multiple if it intensifies materially.

BUY. Conviction Score: 66/100. The view would shift towards a downgrade on a documented slowdown in organic revenue growth to mid-single digits or lower, or on material adverse regulatory action affecting a major market.

Bottom line - BUY at 66/100.

Trim / take some off. Current price USD 39.03 is 2.7% above the trim line of USD 38.00. Existing holders should reduce; new money should wait.

REDUCE ZONEBUY · 66/100Now USD 39.03 · buy ≤ USD 30.00 · trim ≥ USD 38.00

Thesis break: A material adverse regulatory ruling or enforcement action in a major market that constrains data use or imposes significant remediation costs, or organic revenue growth falling below mid-single digits for two consecutive reporting periods, would invalidate the investment thesis regardless of price.

Business Model

Experian generates revenue by selling credit information, analytics and decisioning software to financial institutions, insurers, telecoms operators, retailers, public-sector organisations and, increasingly, to consumers directly through subscription services. The largest revenue stream is the North America Consumer Credit operation, complemented by the Latin America and Europe, Middle East and Africa (EMEA) Consumer Credit operations, an Asia-Pacific segment, a Consumer Services arm that sells credit-monitoring products to individuals, and a Decisioning, Analytics and Software Solutions (DSS) unit that provides higher-value analytics and fraud tools.

Revenue is largely recurring and contract-based, with customers integrating Experian data and software into their underwriting and account-management workflows. The principal unit-economics driver is organic revenue growth, which management has guided to and which was reported at 8% in the most recent half-year period; benchmark earnings per share management grew 15% in the same period, demonstrating operating leverage on the cost line. We do not have a separately disclosed gross or operating margin figure for the current period in the provided data, but the EPS-to-revenue growth differential indicates positive margin expansion.

The competitive moat rests on regulated access to consumer credit data at scale, deep integration into lender decisioning systems that creates meaningful switching friction, and a brand position that supports the consumer subscription business. Higher-value products such as fraud prevention, identity verification and analytical software command better unit economics than core bureau data and have been the focus of management investment, shifting the mix gradually away from pure credit-file provision.

Financial Snapshot

Price

USD 39.03

Market Cap

USD 28.5bn

52w High

USD 49.00

52w Low

USD 31.25

Distance from 52wH

-20.3%

Beta

1.22

Avg Volume

1403

Currency

USD

Recent Catalysts

[Q2 2026 / 12 November 2025] - Experian held its Q2 2026 earnings call on 12 November 2025, at which it discussed ongoing momentum in revenue and earnings growth and addressed integration of artificial-intelligence tooling into the platform. Source: Seeking Alpha earnings call transcript; earningscall.biz.

[H1 2026] - Experian reported strong half-year 2026 financial performance, with 8% organic revenue growth and continued expansion in benchmark earnings per share. Source: Yahoo Finance; TipRanks company announcement.

[FY2026] - Experian delivered record full-year 2026 results, with 8% organic revenue growth and 15% benchmark EPS growth, alongside the announcement of an additional $1 billion share repurchase authorisation. Source: Yahoo Finance earnings highlights summary.

[2026, prior to this report] - The share buyback programme was extended with a fresh $1 billion authorisation alongside the FY2026 results, supporting the per-share earnings trajectory. Source: Yahoo Finance earnings highlights summary.

Thesis Evaluation

Bull Case (33% weight)

Experian sustains organic revenue growth of 8% or above, expands benchmark EPS at a double-digit pace and lifts margin through a continued mix shift into higher-value decisioning and fraud products, while executing the $1 billion buyback efficiently. In this scenario the rating multiple re-rates modestly higher as the regulatory backdrop remains benign. Price target: 42.00 USD over a 12-month horizon.

Base Case (51% weight)

Organic revenue growth normalises to the high-single-digit range, benchmark EPS growth continues in the low-to-mid teens and capital returns via the buyback support the share price without driving a multiple re-rate. Margin expansion is steady but unspectacular, and the regulatory backdrop produces no material adverse action. Price target: 38.00 USD over a 12-month horizon.

Bear Case (16% weight)

Regulatory action in a major market constrains data use or imposes fines and remediation costs that compress margin, while organic revenue growth decelerates to mid-single digits as lender demand softens. The premium multiple contracts materially in this scenario and the share price retraces. Price target: 26.00 USD over a 12-month horizon.

Weighted conviction:Bull (33%) x 100 + Base (51%) x 62 + Bear (16%) x 10 = 66/100. BUY.

Key Risks

Regulatory scrutiny on data use and consumer protection: A material enforcement action or new compliance obligation in North America or EMEA could constrain revenue or impose remediation costs, and is the principal risk to the rating multiple. Estimated probability: 35%. Impact: severe.
Organic revenue growth deceleration: A slowdown in lender demand or consumer subscription volumes to mid-single digits or below would reduce operating leverage and undermine the EPS growth narrative. Estimated probability: 25%. Impact: moderate.
Multiple compression from re-rating: With a trailing P/E around 19x and limited margin of safety on valuation, even modest disappointment on growth or margins can produce a sharp share price drawdown. Estimated probability: 30%. Impact: moderate.
Currency translation drag: With reporting in USD and operations spanning multiple currencies, adverse FX movements can reduce reported growth even when underlying business performance is unchanged. Estimated probability: 40%. Impact: low.
Execution risk on capital returns: The announced $1 billion buyback is supportive of EPS but only delivers value if executed at attractive levels and not unwound by offsetting dilutive actions. Estimated probability: 15%. Impact: low.

Who Should Own It / Avoid It

Ideal for: long-term, quality-growth investors with a minimum holding period of three to five years, a moderate-to-high risk tolerance and a willingness to accept regulatory and valuation risk in exchange for recurring, contract-based revenue and visible capital returns. The name suits a core holding within a diversified portfolio rather than a tactical trade.

Avoid if: an investor is unwilling to tolerate regulatory headline risk in the data and credit-information sector, an investor requires a deep margin of safety on valuation before buying a growth franchise, or an investor is constrained to a short holding period under twelve months. Investors uncomfortable with the premium trailing multiple of approximately 19x P/E should also pass.

Recommendation

BUY - 66/100. The BUY tier reflects the combination of demonstrated organic revenue growth, double-digit benchmark EPS expansion and a fresh $1 billion buyback, set against acknowledged regulatory risk that prevents the conviction from reaching the highest tier. The call would be upgraded on evidence of regulatory stability in major markets combined with sustained organic growth at or above 8%, which would justify a higher rating multiple. The call would be downgraded on documented organic revenue deceleration to mid-single digits or below, on a material adverse regulatory outcome in a major market, or on a sustained period of negative currency translation that obscures underlying performance. At the current price of $39.03 the shares trade at or above our base-case target of $38.00: the base case is fully priced, existing holders should consider trimming, and new positions are not advised above $30.00.

The probability-weighted value across our three scenarios is $37.40, 4% below the current price of $39.03 - the market is currently pricing the shares ahead of our probability-weighted view. Levels below are derived from the scenario targets and probabilities above, not from percentage offsets to today's price.

BUY

below $30.00 - below this level the upside to the base-case target ($38.00) is at least 2x the downside to the bear case ($26.00), the minimum risk/reward we require before committing new capital.

HOLD

between $30.00 and $38.00 - the base case is not yet fully priced, so existing holders are paid to wait, but new money gets no margin of safety in this zone.

REDUCE

above $38.00 - at this level the base case is fully reflected in the price and anything beyond it is paying for a bull scenario we weight at 33%.

SELL

if A material adverse regulatory ruling or enforcement action in a major market that constrains data use or imposes significant remediation costs, or organic revenue growth falling below mid-single digits for two consecutive reporting periods, would invalidate the investment thesis regardless of price, regardless of price - the bear target of $26.00 is the backstop, not an arbitrary percentage stop.

Conviction Trend

Latest conviction: 66/100. Trend versus prior report: Initiation.

CONVICTION BUY (80+)BUY (65 - 79)OPP BUY (50 - 64)SPEC BUY (30 - 49)AVOID (0 - 29)

Report date	Conviction
2026-10-04	66

See the trade-card view →

Sources

Market data: DYOR HQ proprietary market data workflow.

Public sentiment and news flow: Public news flow drawn from financial news wires and aggregator coverage of Experian's reporting periods, supplemented by earnings call commentary issued at the relevant results announcements and investor relations materials published by the company.

Primary source types: Earnings call transcripts and accompanying company press releases, investor relations announcements including buyback authorisation updates, regulatory filings in relevant markets, and third-party analyst commentary referencing the underlying filings.

Key sources

Analysis generated 2026-10-04. Market data as of 2026-11-11.